Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | Newcastle University |
| Main Category: | Services |
| Procurement Method: | Restricted procedure |
| Tender Status: | Closed |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
6 December 2022
Closed
Estimated Value
£30,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Estimated Value (ex. VAT): |
| £30,000 |
| Release Date: | 6 February 2023 |
| Application Deadline: | 6 December 2022 |
| Contract Start Date: | 1 February 2023 |
| Contract End Date: | 31 August 2023 |
| Contract Duration: | 7 months |
| Procurement ID (OCID): | ocds-b5fd17-7068d3a9-3405-4fe6-862e-820bf5857987 |
| Notice Reference: | 841afc96-5fe3-4b07-8146-bdfabf52320f-612057 |
View Original Notice
Access the full notice on the official portal
Awarded to
| Award value: | £30,000 |
| Award decision date: | 11 January 2023 |
| Award status: | Active |
The University of Southampton have developed a unique DNA based therapeutic to activate NK cells against cancer. The therapeutic is delivered intramuscularly in combination with DNA encoding the potent immune stimulating cytokine IL-15. The objective is for an Executive to jointly work with the team to bring the opportunity towards and ultimately achieve launch of a new spinout company. The project description is included below: Phase 1 Opportunity Validation and Business Plan Creation - Executive leads all activity; ensures other team members support on relevant technical/ application needs inputs; if requested by Exec, UoS R&IS department will assist defining business plan requirements Phase 2 Research organisation Approval In Principle to Spinout - Executive briefed by UoS R&IS on relevant documentation, and assisted by that team to complete this and submit to first available regular bi-monthly Southampton Enterprise Board meetings; Attendance of networking conferences to accelerate commercialisation process. Phase 3 Achieve "Ready to Spin" status Phase 4 Investor willingness to complete necessary funding round;